Introduction: Linkage, Engagement, and Retention in HIV Care: Essential for Optimal Individual- and Community-Level Outcomes in the Era of Highly Active Antiretroviral Therapy-Reference-Cited by-同舟云学术

Introduction: Linkage, Engagement, and Retention in HIV Care: Essential for Optimal Individual- and Community-Level Outcomes in the Era of Highly Active Antiretroviral Therapy

Published:2011-01-15 Issue:suppl_2 Volume:52 Page:S205-S207
ISSN:1537-6591
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Mayer Kenneth Hugh

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/52/suppl_2/S205/20909213/ciq043.pdf

Reference22 articles.

1. Retention in care: a challenge to survival with HIV infection;Giordano;Clin Infect Dis,2007

2. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras;Crum;J Acquir Immune Defic Syndr,2006

3. The survival benefits of AIDS treatment in the United States;Walensky;J Infect Dis,2006

4. Estimation of HIV incidence in the United States;Hall;JAMA,2008

5. Undiagnosed HIV prevalence among adults and adolescents in the United States at the end of 2006;Campsmith;J Acquir Immune Defic Syndr,2010

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinic-level complexities prevent effective engagement of people living with HIV who are out-of-care;PLOS ONE;2024-05-31

2. A review of the clinical characteristics and management of immunosuppressed patients living with HIV or solid organ transplants infected with SARS-CoV-2 omicron variants;Frontiers in Public Health;2024-02-22

3. Provider perspectives on healthcare provision via telemedicine to persons with HIV living in an urban community;Health Policy and Technology;2024-02

4. Individuals with HIV are likely targets for long COVID;AIDS;2023-11-20

5. Identification of the Imidazo[1,2-a]pyrazine Derivative A4 as a Potential Influenza Virus Nucleoprotein Inhibitor;ACS Pharmacology & Translational Science;2023-11-17